Noticias de VERU_US
Noticias del mercado
Últimas noticias sobre VERU_US — 73 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Veru Inc. Earnings Call Highlights Clinical Momentum
Veru SEC Filings
Veru Inc (VERU) Q2 2026 Earnings Call Highlights: Promising Clin
Q2 2026 Veru Inc Earnings Call Transcript
Veru Q2 2026: -$0.12 EPS Tops Estimates — Deep Dive
Veru Q2 2026 earnings preview
Veru Inc. (VERU) Reports Positive Phase IIb Trial Results and On
Veru Inc. 2026 Q2 Financial Report: Key Risks, Results, and Clinical Trial Updates
Veru Posts Narrower Q2 2026 Loss of -$0.12, 57.1% Better Than Forecast
Veru Inc. (VERU) Reports Q2 Earnings, EPS Exceeds Expectations
VERU: Phase II-B data show enobosarm preserves muscle and function, with improved financials and strong cash
Veru Releases Q2 2026 Financial Results
Veru Inc reports results for the quarter ended March 31 - Earnings Summary
Earnings call transcript: Veru Inc Q2 2026 shows improved financials
VERU: Enobosarm preserves muscle and function in older obese patients; losses narrowed, cash improved
VERU INC. 3Q 2026: Revenue $0 Net loss $2.74M, EPS $(0.12) — 10-Q Summary
Veru (NASDAQ: VERU) narrows loss but warns on going concern and funding needs
Transcript: Veru Q2 2026 Earnings Conference Call
VERU Reports Financial Growth and Clinical Trial Progress
Veru 2Q Loss/Shr 12c >VERU
Página 1 de 4
